CLLS

Cellectis S.A. - American Depositary Shares (CLLS)

About Cellectis S.A. - American Depositary Shares (CLLS)

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.

Details

Daily high

$1.55

Daily low

$1.45

Price at open

52 Week High

$5.48

52 Week Low

$1.25

Market cap

110.7M

Dividend yield

Volume

369

Avg. volume

185,103

P/E ratio

-2.35

Cellectis S.A. - American Depositary Shares News